Legal & General Group’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,180
Closed -$7K 3460
2022
Q2
$7K Sell
3,180
-1,294
-29% -$2.97K ﹤0.01% 3412
2022
Q1
$14K Buy
4,474
+295
+7% +$1.06K ﹤0.01% 3317
2021
Q4
$18K Hold
4,179
﹤0.01% 3305
2021
Q3
$34K Sell
4,179
-176
-4% -$1.43K ﹤0.01% 3083
2021
Q2
$33K Sell
4,355
-322
-7% -$2.71K ﹤0.01% 3102
2021
Q1
$41K Sell
4,677
-209
-4% -$1.99K ﹤0.01% 2880
2020
Q4
$39K Hold
4,886
﹤0.01% 2869
2020
Q3
$39K Sell
4,886
-805
-14% -$7.26K ﹤0.01% 2770
2020
Q2
$56K Buy
5,691
+782
+16% +$7.18K ﹤0.01% 2695
2020
Q1
$34K Sell
4,909
-1,310
-21% -$6.61K ﹤0.01% 2721
2019
Q4
$24K Buy
6,219
+1,196
+24% +$5.22K ﹤0.01% 3130
2019
Q3
$25K Hold
5,023
﹤0.01% 3055
2019
Q2
$33K Hold
5,023
﹤0.01% 2961
2019
Q1
$38K Hold
5,023
﹤0.01% 2813
2018
Q4
$41K Buy
5,023
+788
+19% +$7.83K ﹤0.01% 2768
2018
Q3
$55K Hold
4,235
﹤0.01% 2726
2018
Q2
$48K Buy
+4,235
New +$40.1K ﹤0.01% 2764

Other funds holding CTSO

Legal & General Group's CTSO Position: Q3 2022 in Review

Legal & General Group sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 3,180 shares — an estimated $7K sold.

Legal & General Group first reported a position in CTSO in Q2 2018 and held it in 17 quarters. The position peaked at $56K in Q2 2020. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

  • Legal & General Group reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
  • Legal & General Group sold 3,180 Cytosorbents Corp shares in Q3 2022, an estimated $7K.
  • Legal & General Group first reported a position in Cytosorbents Corp in Q2 2018 and held it in 17 quarters.
  • Legal & General Group's Cytosorbents Corp position peaked at $56K in Q2 2020.
  • 60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on Legal & General Group's 13F filing for Q3 2022, filed 14 Nov 2022.